College of Pharmacy

Master’s Thesis Defense: Impact of GLP-1 Receptor Agonists on the Well-being of Obese Patients
The College of Pharmacy at the University of Mosul hosted the Master’s thesis defense of the student Aya Saad Saeed on Thursday, December 18. Her research, titled “The Impact of GLP-1 Receptor Agonists on the Well-being of Obese Patients,” was presented in the college’s seminar hall.
The thesis focused on evaluating the safety and efficacy of GLP-1 Receptor Agonists (GLP-1 RAs) on the quality of life and dietary behavior among Iraqi adults struggling with obesity. Pharmacovigilance results revealed distinct safety profiles; Semaglutide was associated with more pronounced gastrointestinal and neuropsychiatric signals, whereas Tirzepatide appeared relatively safer.
Key Findings:
* Behavioral Correlation: The study indicated that a high Body Mass Index (BMI) is linked to increased emotional eating and reduced satiety.
* Clinical Improvement: Users of GLP-1 medications showed significant improvements in quality of life and appetite control.
* Holistic Approach: The persistence of emotional eating in some cases underscores the necessity of integrating pharmacological treatment with behavioral and psychological support for sustainable results.
The session was attended by the Dean, Professor Dr. Yasser Fakhry Mustafa, along with several faculty members and postgraduate students.
The Examination Committee consisted of:
* Prof. Dr. Harith Khalid Al-Qazzaz (University of Mosul) – Chairman.
* Asst. Prof. Dr. Kadhim Ali Kadhim (Al-Mustansiriya University) – Member.
* Asst. Prof. Dr. Mohammed Abdul-Kareem Younis (University of Mosul) – Member.
* Asst. Prof. Dr. Mohammed Ibrahim Al-Adool (University of Mosul) – Member and Supervisor.
The committee praised the scientific rigor of the thesis and its relevance to modern obesity management. The thesis was accepted with minor revisions.